Molecular Basis of the Mechanism of Action
At the biochemical level, Atropinum functions as a typical competitive inhibitor. This means the drug molecule shares structural similarity with the endogenous ligand and competes with it for the binding site.
The sequence of events in the synapse is as follows:
- The atropine molecule recognizes the active site of the muscarinic acetylcholine receptor and reversibly binds to it.
- The natural neurotransmitter of the parasympathetic nervous system (acetylcholine) loses its ability to bind to the occupied receptor.
- As a result, nerve impulse transmission at parasympathetic synapses is completely blocked, leading to systemic changes in internal organ function.
Clinical Applications
Understanding the mechanism of competitive muscarinic receptor blockade allows this belladonna alkaloid to be used across various medical specialties:
- Ophthalmology: Blockade of receptors in the eye causes relaxation of the circular iris muscle (sphincter pupillae). This leads to pronounced pupil dilation (mydriasis), which is necessary for thorough ophthalmoscopy.
- Anesthesiology: Administered during pre-anesthetic medication. It reliably decreases salivary and bronchial secretions and prevents dangerous reflex cardiac arrest during anesthesia.
- Cardiology: The drug's ability to block parasympathetic influences on the myocardium is used to treat bradycardia and atrioventricular (AV) blocks.
- Gastroenterology: Atropine acts as a potent antispasmodic, relieving painful smooth muscle spasms of the gastrointestinal tract.
- Toxicology: Serves as a critical antidote in poisonings caused by muscarine and organophosphates.
Principles of Overdose Management
Because atropine is a competitive antagonist, its effects can be overcome. The primary biochemical goal in an overdose is to maximize the concentration of acetylcholine in the synaptic cleft.
According to the law of mass action, an excess of the substrate (acetylcholine) will displace the inhibitor (atropine) from the receptor.
To achieve this, specific antidote medications are used — acetylcholinesterase inhibitors (such as physostigmine or neostigmine). These agents temporarily block the enzyme that normally degrades acetylcholine. Consequently, the endogenous neurotransmitter rapidly accumulates in the synapse in massive amounts, restoring nerve impulse transmission and displacing the poison molecules.